[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NL194431B - Farmaceutische preparaten die ranitidine bevatten. - Google Patents

Farmaceutische preparaten die ranitidine bevatten.

Info

Publication number
NL194431B
NL194431B NL8703000A NL8703000A NL194431B NL 194431 B NL194431 B NL 194431B NL 8703000 A NL8703000 A NL 8703000A NL 8703000 A NL8703000 A NL 8703000A NL 194431 B NL194431 B NL 194431B
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparations
preparations containing
containing ranitidine
ranitidine
pharmaceutical
Prior art date
Application number
NL8703000A
Other languages
English (en)
Other versions
NL8703000A (nl
NL194431C (nl
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10608930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL194431(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8703000A publication Critical patent/NL8703000A/nl
Publication of NL194431B publication Critical patent/NL194431B/nl
Application granted granted Critical
Publication of NL194431C publication Critical patent/NL194431C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
NL8703000A 1986-12-12 1987-12-11 Farmaceutische preparaten die ranitidine bevatten. NL194431C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8629781 1986-12-12
GB868629781A GB8629781D0 (en) 1986-12-12 1986-12-12 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NL8703000A NL8703000A (nl) 1988-07-01
NL194431B true NL194431B (nl) 2001-12-03
NL194431C NL194431C (nl) 2002-04-04

Family

ID=10608930

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8703000A NL194431C (nl) 1986-12-12 1987-12-11 Farmaceutische preparaten die ranitidine bevatten.

Country Status (23)

Country Link
US (1) US5068249A (nl)
JP (1) JP2590156B2 (nl)
KR (1) KR960008228B1 (nl)
AT (1) AT395373B (nl)
AU (1) AU607451B2 (nl)
BE (1) BE1000624A5 (nl)
CA (1) CA1303993C (nl)
CH (1) CH675207A5 (nl)
CZ (1) CZ281599B6 (nl)
DE (1) DE3742127C2 (nl)
DK (1) DK167842B1 (nl)
FR (1) FR2608921B1 (nl)
GB (2) GB8629781D0 (nl)
HK (1) HK19095A (nl)
IE (1) IE60618B1 (nl)
IL (1) IL84795A0 (nl)
IT (1) IT1211967B (nl)
NL (1) NL194431C (nl)
NZ (1) NZ222879A (nl)
PH (1) PH25390A (nl)
SE (1) SE504333C2 (nl)
YU (1) YU46561B (nl)
ZA (1) ZA879338B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL114464A0 (en) * 1994-07-06 1995-11-27 Farmarc Nederland Bv Inclusion complexes of ranitidine
HU213598B (en) * 1994-10-18 1997-08-28 Ge Lighting Tungsram Rt One-side socketed discharge lamp
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
GB9715423D0 (en) * 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
AU2007275606B9 (en) * 2006-07-21 2013-09-26 Lyne Laboratories, Inc. Liquid compositions of calcium acetate
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (de) * 1977-08-06 1979-02-15 Sandoz Ag Stabile loesungen und verfahren zu deren herstellung
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3108753A1 (de) * 1981-03-07 1982-09-16 Degussa Ag, 6000 Frankfurt Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
JPS59101478A (ja) * 1982-11-29 1984-06-12 Sunstar Inc リグスチライドを安定に配合した水系組成物
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer

Also Published As

Publication number Publication date
SE8704952L (sv) 1988-06-13
AU8244487A (en) 1988-06-16
BE1000624A5 (fr) 1989-02-21
GB2198352A (en) 1988-06-15
DK652787D0 (da) 1987-12-11
DK167842B1 (da) 1993-12-27
IT8748698A0 (it) 1987-12-11
KR960008228B1 (ko) 1996-06-21
IL84795A0 (en) 1988-05-31
DK652787A (da) 1988-06-13
FR2608921B1 (fr) 1991-04-12
DE3742127C2 (de) 1997-08-28
PH25390A (en) 1991-06-03
CZ281599B6 (cs) 1996-11-13
JPS63215622A (ja) 1988-09-08
CA1303993C (en) 1992-06-23
DE3742127A1 (de) 1988-10-06
US5068249A (en) 1991-11-26
SE8704952D0 (sv) 1987-12-11
SE504333C2 (sv) 1997-01-13
JP2590156B2 (ja) 1997-03-12
FR2608921A1 (fr) 1988-07-01
NZ222879A (en) 1990-08-28
IT1211967B (it) 1989-11-08
ATA327387A (de) 1992-05-15
GB2198352B (en) 1990-11-28
AU607451B2 (en) 1991-03-07
IE60618B1 (en) 1994-07-27
NL8703000A (nl) 1988-07-01
KR880007060A (ko) 1988-08-26
AT395373B (de) 1992-12-10
ZA879338B (en) 1989-02-22
CS403791A3 (en) 1992-08-12
CH675207A5 (nl) 1990-09-14
GB8629781D0 (en) 1987-01-21
GB8728957D0 (en) 1988-01-27
HK19095A (en) 1995-02-17
NL194431C (nl) 2002-04-04
YU224587A (en) 1990-10-31
YU46561B (sh) 1993-11-16
IE873367L (en) 1988-06-12

Similar Documents

Publication Publication Date Title
DE3783437D1 (de) Heilmittel.
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
DK413987D0 (da) Farmaceutiske praeparater
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI872733A0 (fi) Farmaceutiska kompositioner.
NL194431B (nl) Farmaceutische preparaten die ranitidine bevatten.
FI872313A0 (fi) Farmaceutiska kompositioner.
NO862439D0 (no) Farmasoeytiske preparater.
DE3682960D1 (de) Pharmazeutische praeparate.
FI850455L (fi) Farmaceutiska produkter.
NO874193D0 (no) Farmasoeytiske preparater.
DE3763519D1 (de) Heilnahrungsmittel.
FI874414A (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
DK447887A (da) Frysetoerrede farmaceutiske praeparater
FR2600889B1 (fr) Preparations veterinaires.
FI875616A (fi) Farmaceutiska blandningar.
NO882264L (no) Legemiddelpakning.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
NO875121D0 (no) Medikamenteringsform.
MX9203545A (es) Formulaciones farmaceuticas.
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
IT8719708A0 (it) Formulazione farmaceutica.
ATE64535T1 (de) Xylometazolinhaltige pharmazeutische praeparate.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20071211